A new therapeutic approach to treat diabetic retinopathy. (Innolink: 101.499 IP-LS)

• Forschungsstelle: INNOSUISSE
• Projektnummer: 101.499 IP-LS
• Projekttitel Englisch: A new therapeutic approach to treat diabetic retinopathy. (Innolink: 101.499 IP-LS)

Schlüsselwörter (Englisch)

Life sciences, Pharmaceuticals

Abstract (Englisch)

Diabetic retinopathy is the most common diabetes-specific complication that can lead to blindness due to microvascular damage and breakdown of the blood-retinal barrier. Based on our unique mode of action drug that increases cGMP levels, we aim to restore healthy ocular microcirculation.